Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug with characteristics of rapid transaminase lowering and live protection

A transaminase and drug technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., to achieve high cure rate, high safety, and rapid effect

Active Publication Date: 2012-10-17
源圣太(广州)生物科技有限公司
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there is no hepatoprotective drug that can quickly reduce transaminase and prevent rebound in clinical practice.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug with characteristics of rapid transaminase lowering and live protection
  • Drug with characteristics of rapid transaminase lowering and live protection
  • Drug with characteristics of rapid transaminase lowering and live protection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033]

[0034] The present invention is produced by Jiangsu Yihai Pharmaceutical Co., Ltd. and adopts the conventional process of traditional Chinese medicine preparation to make capsules. 0.45g per capsule.

experiment example 1

[0035] Clinical experiment example 1: for the treatment of elevated transaminases.

[0036] normal information

[0037] A total of 122 cases of patients with elevated transaminases were observed, and both groups of patients were from outpatient clinics. The diagnoses of all cases of patients conformed to the diagnostic criteria established by the 2000 (Xi'an) National Conference on Infectious Diseases.

[0038] Randomly divided into a treatment group and a control group, 61 cases in the treatment group, 46 males and 15 females; 61 cases in the control group, 45 males and 16 females; the disease course of the two groups was half a year to 3.5 years, and the average age was 37±8 years old; There was no history of strong enzyme-lowering drugs in the two groups within 3 months before treatment.

[0039] treatment method

[0040] Treatment group: oral administration of drug capsules of the present invention (produced by Jiangsu Yihai Pharmaceutical Co., Ltd.), 4 capsules (0.45 g...

experiment example 2

[0053] Clinical trial example 2: for non-alcoholic fatty liver (NAFL)

[0054] A total of 106 patients with NAFL were observed. The effect of treatment was observed by self-control method. All patients were from outpatient clinics. Among them, there were 75 males and 31 females; the age was (39±8) years old; the course of disease was 1 year to 12 years and 6 months; 79 cases were obese, with an average body mass index of 27.86.

[0055] Therapeutic method: all patients take the drug capsules of the present invention (produced by Jiangsu Yihai Pharmaceutical Co., Ltd.), 4 capsules (0.45g each) / time, 3 times / day. Treatment for 3 months is a course of treatment, and the observation indicators are re-examined to determine the curative effect.

[0056] Diagnostic criteria: According to the "Diagnostic Criteria for Non-alcoholic Fatty Liver (Draft)" formulated by the Fatty Liver and Alcoholic Liver Disease Group of the Hepatology Society of the Chinese Medical Association, anyone...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a drug with characteristics of rapid transaminase lowering and live protection. According to the drug, common floweringquine fruit, medlar, heartleaf houttuynia herb, dandelion, cape jasmine, malt, peach seed, common jujube, common yam rhizome, tuckahoe, hawthorn, seabuckthorn fruit, seasoned orange peel, perilla frutescens, ma-yuen jobstears seed and licorice root are adopted as raw materials, and the drug can be prepared into any one oral formulation according to a preparation process of traditional Chinese drug pharmacy. Results of clinical observation and laboratory data show that the drug of the present invention provides significant rapid lowering effects for transaminase increasing caused by various liver damages, provides a certain release and treatment effects for fatty liver, and the clinical observation does not show toxic and side-effects.

Description

technical field [0001] The invention relates to a drug for rapidly reducing transaminase and protecting the liver, in particular to a drug for rapidly reducing transaminase and liver protection, which is made from plant traditional Chinese medicines, all of which are traditional Chinese medicine health care products or traditional Chinese medicines for both medicine and food, and has the function of treating both symptoms and root causes. Hepatoprotective drugs. Background technique [0002] Elevated transaminases and liver dysfunction caused by various liver diseases are common clinical symptoms. In particular, the elevation of transaminases caused by hepatitis B, hepatitis C and other hepatitis is very common; liver damage caused by alcohol is also common in clinical practice; the incidence of fatty liver caused by unscientific diet and other reasons is increasing year by year rising trend. [0003] Fatty liver is a comprehensive metabolic disease, which is caused by the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8998A61P1/16
Inventor 王忠民
Owner 源圣太(广州)生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com